TABLE 2.
Bacterial strains used in this study
| Strain | Description | Reference |
|---|---|---|
| MGAS2221 | Invasive clinical isolate, emm1 | 41 |
| M1-SC-1 | Clinical isolate, emm1 | 37 |
| MSPY1 | Clinical isolate, emm89 | 69 |
| SAS-M4-Duke | Clinical isolate, emm4 | 43 |
| RLGH | Clinical isolate, emm4 | 43 |
| Duke Large | Invasive clinical isolate, coisolated with SAS-M4-Duke, inactive CovS | 44 |
| Duke ΔcovS | Isogenic mutant of SAS-M4-Duke, CovS inactive | 44 |
| MGAS10870 | Clinical isolate, emm3 | 70 |
| TSPY416 | emm68 | This study |
| TSPY125 | Clinical isolate, emm83 | This study |
| TSPY155 | Clinical isolate, emm11 | 62 |
| TSPY453 | Clinical isolate, emm77 | 62 |
| TSPY1309 | Clinical isolate, emm63 | This study |
| TSPY136 | Clinical isolate, emm22 | This study |
| MGAS6180 | Clinical isolate, emm28 | 36 |
| MGAS6180 ΔhsdM | Isogenic hsdM mutant | This study |
| TSPY1057 | Clinical isolate, emm87 | 71 |
| TSPY1057 ΔhsdM | Isogenic hsdM mutant | This study |